The mission of the National Institute of Biomedical Imaging and Bioengineering (NIBIB) is to transform through technology development, our understanding of disease and its prevention, detection, diagnosis, and treatment.
Contact Us
A new fluorescent imaging probe can for the first time objectively and non-invasively measure loss of smell, clinically known as anosmia. Targeting the olfactory nerve, the new tool has potential to eliminate biopsies used to diagnose certain anosmia conditions and to aid in the development of therapeutic interventions. This research, funded in part by NIBIB, was published in the August issue of The Journal of Nuclear Medicine.
Source: Society of Nuclear Medicine and Molecular Imaging News
New research from a Florida State University professor and colleagues explains the mathematics behind how initial predispositions and additional information affect decision making.
The research team’s findings show that when decision makers quickly come to a conclusion, the decision is more influenced by their initial bias, or a tendency to err on the side of one of the choices presented. If decision makers wait to gather more information, the slower decision will be less biased. Source: Florida State University News
A team of NIBIB-funded researchers recently developed an AI platform that can analyze 3D pathology images to predict disease outcomes. Their method had improved performance in predicting prostate cancer outcomes when compared with traditional pathology approaches, such as analysis by expert pathologists using 2D images.
The 6th installment of the NIBIB National Technology Centers Webinar Series will be presented Aug. 23, 2024 and will showcase centers specializing in Immunoengineering, Tissue Engineering and Tissue Manufacturing.
This meeting aims to facilitate meaningful research connections by introducing extramural investigators to NIH resources and IRP engineers, scientists, and clinicians.
The fifth installment of the NIBIB National Technology Centers (NCBIB) Webinar Series showcases the three additional centers specializing in Magnetic Resonance Imaging (MRI) methods for biomedical research and clinical translation.
The National Academies will host a hybrid public workshop to explore the application of artificial intelligence (AI) in neuroscience research and discuss how neuroscientific discoveries have aided in the development and advancement of AI technologies.
The fourth installment of the NIBIB National Technology Centers (NCBIB) Webinar Series showcases the first three centers specializing in Magnetic Resonance Imaging (MRI) methods for biomedical research and clinical translation. Gain insights into the latest advancements in tools and technologies developed by NIBIB-funded P41 Centers.